BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38926687)

  • 1. Characterization and genetic analysis of extensively drug-resistant hospital acquired Pseudomonas aeruginosa isolates.
    Abdelaziz MA; El-Aziz AMA; El-Sokkary MMA; Barwa R
    BMC Microbiol; 2024 Jun; 24(1):225. PubMed ID: 38926687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of clinical extensively drug-resistant Pseudomonas aeruginosa in the Hunan province of China.
    Li J; Zou M; Dou Q; Hu Y; Wang H; Yan Q; Liu WE
    Ann Clin Microbiol Antimicrob; 2016 May; 15(1):35. PubMed ID: 27215335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa epidemic high-risk clones and their association with horizontally-acquired β-lactamases: 2020 update.
    Del Barrio-Tofiño E; López-Causapé C; Oliver A
    Int J Antimicrob Agents; 2020 Dec; 56(6):106196. PubMed ID: 33045347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in central Pakistan.
    Saleem S; Bokhari H
    J Infect Public Health; 2020 Apr; 13(4):598-605. PubMed ID: 31564530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular epidemiology and multidrug resistance mechanisms of Pseudomonas aeruginosa isolates from Bulgarian hospitals.
    Vatcheva-Dobrevska R; Mulet X; Ivanov I; Zamorano L; Dobreva E; Velinov T; Kantardjiev T; Oliver A
    Microb Drug Resist; 2013 Oct; 19(5):355-61. PubMed ID: 23600605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of blaGES-5 and bla veb-1 genes with multidrug-resistant extend, pandrug resistance patterns (MDR, XDR, PDR), and biofilm formation in Pseudomonas aeruginosa isolates.
    Ali FA; Bakir SH; Haji SH; Hussen BM
    Cell Mol Biol (Noisy-le-grand); 2021 Nov; 67(3):52-60. PubMed ID: 34933733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of carbapenem resistance mechanisms in clinical isolates of XDR Pseudomonas aeruginosa.
    De Rosa A; Mutters NT; Mastroianni CM; Kaiser SJ; Günther F
    Eur J Clin Microbiol Infect Dis; 2019 Aug; 38(8):1547-1552. PubMed ID: 31152264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
    Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.
    Tchakal-Mesbahi A; Metref M; Singh VK; Almpani M; Rahme LG
    Burns; 2021 Dec; 47(8):1833-1843. PubMed ID: 33795157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): Molecular typing of superbug strains in bloodstream infections (BSI).
    Tahmasebi H; Dehbashi S; Arabestani MR
    Infect Genet Evol; 2020 Nov; 85():104518. PubMed ID: 32891877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PME and Other ESBL-Positive Multiresistant Pseudomonas aeruginosa Isolated from Hospitalized Patients in the Region of Kurdistan, Iraq.
    van Burgh S; Maghdid DM; Ganjo AR; Mansoor IY; Kok DJ; Fatah MH; Alnakshabandi AA; Asad D; Hammerum AM; Ng K; Klaassen C; Goessens WHF
    Microb Drug Resist; 2019; 25(1):32-38. PubMed ID: 30067166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology.
    Del Barrio-Tofiño E; Zamorano L; Cortes-Lara S; López-Causapé C; Sánchez-Diener I; Cabot G; Bou G; Martínez-Martínez L; Oliver A;
    J Antimicrob Chemother; 2019 Jul; 74(7):1825-1835. PubMed ID: 30989186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
    Del Barrio-Tofiño E; López-Causapé C; Cabot G; Rivera A; Benito N; Segura C; Montero MM; Sorlí L; Tubau F; Gómez-Zorrilla S; Tormo N; Durá-Navarro R; Viedma E; Resino-Foz E; Fernández-Martínez M; González-Rico C; Alejo-Cancho I; Martínez JA; Labayru-Echverria C; Dueñas C; Ayestarán I; Zamorano L; Martinez-Martinez L; Horcajada JP; Oliver A
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The increasing threat of Pseudomonas aeruginosa high-risk clones.
    Oliver A; Mulet X; López-Causapé C; Juan C
    Drug Resist Updat; 2015; 21-22():41-59. PubMed ID: 26304792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming.
    Fan X; Wu Y; Xiao M; Xu ZP; Kudinha T; Bazaj A; Kong F; Xu YC
    Sci Rep; 2016 May; 6():26522. PubMed ID: 27198004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a University Hospital in Turkey.
    Ozgumus OB; Caylan R; Tosun I; Sandalli C; Aydin K; Koksal I
    Microb Drug Resist; 2007; 13(3):191-8. PubMed ID: 17949306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emergence of extensive drug resistance and high prevalence of multidrug resistance among clinical Proteus mirabilis isolates in Egypt.
    ElTaweel M; Said HS; Barwa R
    Ann Clin Microbiol Antimicrob; 2024 May; 23(1):46. PubMed ID: 38790053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, Risk Factors, and Molecular Epidemiology of Intestinal Carbapenem-Resistant Pseudomonas aeruginosa.
    Hu Y; Qing Y; Chen J; Liu C; Lu J; Wang Q; Zhen S; Zhou H; Huang L; Zhang R
    Microbiol Spectr; 2021 Dec; 9(3):e0134421. PubMed ID: 34817230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.